EUVIMEDEUVIMED entdecken
Crossref

Xylazine-induced skin lesions: clinical presentation and management perspectives on an emerging drug epidemic

Kritin K. Verma, Jonathan Tipo, Brenna Bunch, Daniel P. Friedmann, Michelle B. Tarbox

Academia Medicine · 10.03.2025 · 2 (1)

DOI: 10.20935/acadmed7572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academia Medicine, online erschienen am 10.03.2025. Verfasst von Kritin K. Verma und 4 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xylazine, a veterinary sedative, has emerged as a significant adulterant in the illicit drug supply, particularly in opioids. Its prevalence has risen dramatically, with detection rates reaching 80% in some areas of the Northeastern United States. Xylazine-associated skin lesions present a unique challenge for healthcare providers, characterized by deep, necrotic ulcers that progress rapidly and are resistant to healing. These wounds often occur both at and away from injection sites due to the vasoconstrictive properties of xylazine. Diagnosis requires a comprehensive approach, including patient history, specialized toxicology screening, and imaging studies. Management of xylazine-associated wounds involves a multidisciplinary strategy encompassing wound care, infection control, and addiction treatment. The DIME (Devitalized tissue, Infection control, Moisture balance, and periwound Edge) framework has been adopted by some clinics for treating these complex injuries. As xylazine contamination continues to spread, healthcare providers must be prepared to recognize and manage its unique clinical presentations.

Zitieren

APA

Verma, K. K., Tipo, J., Bunch, B., Friedmann, D. P., & Tarbox, M. B. (2025). Xylazine-induced skin lesions: clinical presentation and management perspectives on an emerging drug epidemic. Academia Medicine, 2(1). https://doi.org/10.20935/acadmed7572

Vancouver

Verma KK, Tipo J, Bunch B, Friedmann DP, Tarbox MB. Xylazine-induced skin lesions: clinical presentation and management perspectives on an emerging drug epidemic. Academia Medicine. 2025;2(1). doi:10.20935/acadmed7572

BibTeX
@article{Verma2025,
  author = {Verma, Kritin K. and Tipo, Jonathan and Bunch, Brenna and Friedmann, Daniel P. and Tarbox, Michelle B.},
  title = {Xylazine-induced skin lesions: clinical presentation and management perspectives on an emerging drug epidemic},
  journal = {Academia Medicine},
  year = {2025},
  volume = {2},
  number = {1},
  doi = {10.20935/acadmed7572}
}
Kostenlos starten →